Incannex Healthcare (IXHL) Total Non-Current Liabilities (2020 - 2026)

Incannex Healthcare's (IXHL) quarterly Total Non-Current Liabilities came in at $2.0 million in Q1 2026, down 73.65% year-on-year from $7.5 million in Q1 2025, and down 73.65% quarter-over-quarter from $7.5 million in Q1 2025.

Incannex Healthcare (IXHL) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $2.0 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $2.0 million, down 73.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (down 73.65% YoY), and the FY2023 annual result was $616087.0, changed N/A from the prior year.
  • Total Non-Current Liabilities came in at $2.0 million for Q1 2026 at Incannex Healthcare, down from $7.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $8.9 million in Q4 2024 to a low of $616087.0 in Q2 2023.
  • The 4-year median for Total Non-Current Liabilities is $3.5 million (2023), against an average of $4.5 million.
  • Across the five-year window, Total Non-Current Liabilities soared 153.94% in 2024 and plunged 73.65% in 2026, its largest moves.
  • Incannex Healthcare's Total Non-Current Liabilities stood at $3.5 million in 2023, then jumped by 153.94% to $8.9 million in 2024, then decreased by 15.62% to $7.5 million in 2025, then slumped by 73.65% to $2.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $2.0 million (Q1 2026), $7.5 million (Q1 2025), and $8.9 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Incannex Healthcare 45.81 Mn 45.81 Mn - 1.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.97 Mn
Mar 31, 2025 7.47 Mn
Dec 31, 2024 8.86 Mn
Dec 31, 2023 3.49 Mn
Jun 30, 2023 616,087.00
Jun 30, 2020 955,006.00